Literature DB >> 28945203

mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation.

Kaushal Asrani1, Akshay Sood1, Alba Torres1, Dan Georgess2, Pornima Phatak3, Harsimar Kaur1, Amber Dubin1, C Conover Talbot4, Loubna Elhelu1, Andrew J Ewald2,5, Bo Xiao6, Paul Worley6, Tamara L Lotan1,5.   

Abstract

Despite its central position in oncogenic intracellular signaling networks, the role of mTORC1 in epithelial development has not been studied extensively in vivo. Here, we have used the epidermis as a model system to elucidate the cellular effects and signaling feedback sequelae of mTORC1 loss of function in epithelial tissue. In mice with conditional epidermal loss of the mTORC1 components Rheb or Rptor, mTORC1 loss of function unexpectedly resulted in a profound skin barrier defect with epidermal abrasions, blistering, and early postnatal lethality, due to a thinned epidermis with decreased desmosomal protein expression and incomplete biochemical differentiation. In mice with mTORC1 loss of function, we found that Rho kinase (ROCK) signaling was constitutively activated, resulting in increased cytoskeletal tension and impaired cell-cell adhesion. Inhibition or silencing of ROCK1 was sufficient to rescue keratinocyte adhesion and biochemical differentiation in these mice. mTORC1 loss of function also resulted in marked feedback upregulation of upstream TGF-β signaling, triggering ROCK activity and its downstream effects on desmosomal gene expression. These findings elucidate a role for mTORC1 in the regulation of epithelial barrier formation, cytoskeletal tension, and cell adhesion, underscoring the complexity of signaling feedback following mTORC1 inhibition.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28945203      PMCID: PMC5663351          DOI: 10.1172/JCI92893

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  88 in total

1.  RhoE binds to ROCK I and inhibits downstream signaling.

Authors:  Kirsi Riento; Rosa M Guasch; Ritu Garg; Boquan Jin; Anne J Ridley
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

2.  Abl tyrosine kinases regulate cell-cell adhesion through Rho GTPases.

Authors:  Nicole L Zandy; Martin Playford; Ann Marie Pendergast
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-26       Impact factor: 11.205

3.  Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation.

Authors:  Kyung Song; Hui Wang; Tracy L Krebs; David Danielpour
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

4.  Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo.

Authors:  K Foitzik; G Lindner; S Mueller-Roever; M Maurer; N Botchkareva; V Botchkarev; B Handjiski; M Metz; T Hibino; T Soma; G P Dotto; R Paus
Journal:  FASEB J       Date:  2000-04       Impact factor: 5.191

5.  Desmoplakin is essential in epidermal sheet formation.

Authors:  V Vasioukhin; E Bowers; C Bauer; L Degenstein; E Fuchs
Journal:  Nat Cell Biol       Date:  2001-12       Impact factor: 28.824

6.  PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR.

Authors:  Hongbing Zhang; Natalia Bajraszewski; Erxi Wu; Hongwei Wang; Annie P Moseman; Sandra L Dabora; James D Griffin; David J Kwiatkowski
Journal:  J Clin Invest       Date:  2007-02-08       Impact factor: 14.808

7.  Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling.

Authors:  Reema S Wahdan-Alaswad; Kyung Song; Tracy L Krebs; Dorjee T N Shola; Jose A Gomez; Shigemi Matsuyama; David Danielpour
Journal:  Cancer Res       Date:  2010-11-09       Impact factor: 12.701

8.  Plakophilin 2 couples actomyosin remodeling to desmosomal plaque assembly via RhoA.

Authors:  Lisa M Godsel; Adi D Dubash; Amanda E Bass-Zubek; Evangeline V Amargo; Jodi L Klessner; Ryan P Hobbs; Xinyu Chen; Kathleen J Green
Journal:  Mol Biol Cell       Date:  2010-06-16       Impact factor: 4.138

9.  Rho/Rho-associated kinase-II signaling mediates disassembly of epithelial apical junctions.

Authors:  Stanislav N Samarin; Andrei I Ivanov; Gilles Flatau; Charles A Parkos; Asma Nusrat
Journal:  Mol Biol Cell       Date:  2007-06-27       Impact factor: 4.138

Review 10.  Spindle orientation and epidermal morphogenesis.

Authors:  Anita Kulukian; Elaine Fuchs
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-09-23       Impact factor: 6.237

View more
  15 in total

1.  Low-concentration DMSO accelerates skin wound healing by Akt/mTOR-mediated cell proliferation and migration in diabetic mice.

Authors:  Wei Guo; Wei Qiu; Xiang Ao; Weiqiang Li; Xiao He; Luoquan Ao; Xueting Hu; Zhan Li; Ming Zhu; Donglin Luo; Wei Xing; Xiang Xu
Journal:  Br J Pharmacol       Date:  2020-04-07       Impact factor: 8.739

2.  Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer.

Authors:  Kaushal Asrani; Alba Fc Torres; Juhyung Woo; Thiago Vidotto; Harrison K Tsai; Jun Luo; Eva Corey; Brian Hanratty; Ilsa Coleman; Srinivasan Yegnasubramanian; Angelo M De Marzo; Peter S Nelson; Michael C Haffner; Tamara L Lotan
Journal:  J Pathol       Date:  2021-09-23       Impact factor: 7.996

Review 3.  The role of metabolic ecosystem in cancer progression - metabolic plasticity and mTOR hyperactivity in tumor tissues.

Authors:  Anna Sebestyén; Titanilla Dankó; Dániel Sztankovics; Dorottya Moldvai; Regina Raffay; Catherine Cervi; Ildikó Krencz; Viktória Zsiros; András Jeney; Gábor Petővári
Journal:  Cancer Metastasis Rev       Date:  2022-01-14       Impact factor: 9.264

4.  RAS induced senescence of skin keratinocytes is mediated through Rho-associated protein kinase (ROCK).

Authors:  Alex J Lee; Elise Fraser; Brittany Flowers; Jee Kim; Kenneth Wong; Christophe Cataisson; Huaitian Liu; Howard Yang; Maxwell P Lee; Stuart H Yuspa; Luowei Li
Journal:  Mol Carcinog       Date:  2021-09-17       Impact factor: 5.139

5.  Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.

Authors:  Xuexia Zhou; Run Wang; Xuebing Li; Lin Yu; Dan Hua; Cuiyun Sun; Cuijuan Shi; Wenjun Luo; Chun Rao; Zhendong Jiang; Ying Feng; Qian Wang; Shizhu Yu
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

6.  The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models In Vivo Reflects a Complex Balance between Tumor-Suppressive and Proprogression Activities of TGFβ.

Authors:  Yuan Yang; Howard H Yang; Binwu Tang; Alex Man Lai Wu; Kathleen C Flanders; Nellie Moshkovich; Douglas S Weinberg; Michael A Welsh; Jia Weng; Humberto J Ochoa; Tiffany Y Hu; Michelle A Herrmann; Jinqiu Chen; Elijah F Edmondson; R Mark Simpson; Fang Liu; Huaitian Liu; Maxwell P Lee; Lalage M Wakefield
Journal:  Clin Cancer Res       Date:  2019-10-03       Impact factor: 12.531

7.  Telophase correction refines division orientation in stratified epithelia.

Authors:  Kendall J Lough; Kevin M Byrd; Carlos P Descovich; Danielle C Spitzer; Abby J Bergman; Gerard Mj Beaudoin; Louis F Reichardt; Scott E Williams
Journal:  Elife       Date:  2019-12-13       Impact factor: 8.140

8.  mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT/TFE regulation.

Authors:  Kaushal Asrani; Sanjana Murali; Brandon Lam; Chan-Hyun Na; Pornima Phatak; Akshay Sood; Harsimar Kaur; Zoya Khan; Michaël Noë; Ravi K Anchoori; C Conover Talbot; Barbara Smith; Michael Skaro; Tamara L Lotan
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

Review 9.  ROCK 'n TOR: An Outlook on Keratinocyte Stem Cell Expansion in Regenerative Medicine via Protein Kinase Inhibition.

Authors:  Giorgia Centonze; Sara Centonze; Luca Ponzone; Enzo Calautti
Journal:  Cells       Date:  2022-03-27       Impact factor: 6.600

10.  mTOR inhibitors potentially reduce TGF-β2-induced fibrogenic changes in trabecular meshwork cells.

Authors:  Nozomi Igarashi; Megumi Honjo; Makoto Aihara
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.